Crowdonomics
All companies

CANNABIS GLOBAL, INC.

Operating

Biotech · Los Angeles, CA

Estimated pre-money ⓘ
$735K
As of Oct 2022 · from Reg A Offering (2022) · our estimate: offering price × shares outstanding, not a stated valuation
Total raised
$50,000
Crowd $0 · Private $50K · 2 rounds since 2019
Latest share price
$0.001
Reg A Offering (2022) offering price

Financials

FY2006–FY2021 · from SEC filings · hover any figure for its source
$0
−$45K
2014
−$48K
2015
−$8K
2016
−$8K
2017
$0
−$87K
2018
$0
−$390K
2019
$27K
−$4.9M
2020
$1.6M
−$7.8M
2021
RevenueNet income — beside revenue when positive, below the line when a loss

Chart shows the most recent 8 fiscal years; 8 earlier years are in the table below.

Metric
FY2006 audited
FY2007 audited
FY2008 audited
FY2009 audited
FY2010 audited
FY2011 audited
FY2012 audited
FY2013 audited
FY2014 audited
FY2015 audited
FY2016 audited
FY2017 audited
FY2018 audited
FY2019 audited
FY2020 audited
FY2021 audited
Income statement
Revenue
—
—
—
—
—
$0
$0
$0
$0
—
—
—
$0
$0
$27,004
$1,601,037
Cost of goods sold
—
—
—
—
—
—
—
—
—
—
—
—
—
$0
$24,521
$1,416,779
Gross margin
—
—
—
—
—
—
—
—
—
—
—
—
—
—
9%
12%
Net income
-$82,739
-$27,405
-$84,635
-$77,593
-$70,129
-$48,917
-$53,780
-$43,441
-$45,272
-$48,094
-$7,825
-$8,430
-$86,846
-$389,597
-$4,929,348
-$7,834,839
Taxes paid
—
—
—
—
—
—
$0
$0
$0
—
—
—
$0
$0
$0
$0
Balance sheet
Cash
—
—
—
—
$168,464
$115,421
$66,612
$21,135
$51,744
$5,850
$5,012
$4,832
$4,652
$152,082
$2,338
$30,813
Accounts receivable
—
—
—
—
—
—
—
—
—
—
—
—
$0
$0
$0
$113,379
Total assets
—
—
—
—
—
$119,355
$67,400
$21,376
$51,744
$5,850
$5,012
$4,832
$4,652
$214,829
$2,325,185
$11,338,804
Short-term debt
—
—
—
—
—
—
—
—
$70,000
$70,000
$70,000
$70,000
$70,000
$0
$0
$975,043
Long-term debt
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
$1,032,950
Total liabilities
—
—
—
—
—
—
—
$816
$76,456
$78,656
$85,643
$93,893
$139,605
$153,414
$3,760,471
$9,982,997
Other
Headcount
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
3

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$735K
est. pre-money
Reg A+ · Equity · Oct 2022

Dotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.

Cap table

Share counts as of Mar 13, 2023
Series A Preferred Stock · 0.34%Preferred Stock · 0.34%Common Stock · 99.3%
ClassOutstandingVotes / shareShare of totalVotesLiquidationLast price
Series A Preferred Stockpreferred6,000,000500.34%14.7%paid 1st—
Preferred Stockpreferred(as of Aug 31, 2022)6,000,000—0.34%0.29%——
Common Stock1,736,451,314—99.3%85.0%——
Total1,748,451,314100%100%

Shares outstanding over timein today's share terms

741M370M0
Aug 2015Oct 2022
Common StockPreferred StockSeries A Preferred StockRound openedSplit / conversion

Changes in named holdersshares in today's terms · % of all shares at the time

Principal holders% as the filing states it, Jun 5, 2020

  • Dan Van Nguyen2,888,889 Common Stock23.6%of
  • Edward Manolos2,888,889 Common Stock23.6%of
  • Robert L. Hymers III2,888,889 Common Stock23.6%of
  • Jatinder S Bhogal1,533,334 Common Stock12.5%of
  • Arman Tabatabaei800,000 Common Stock6.5%of

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Raised $0 / $500KEst. pre-money $734.9K

Team

2 people
Edward Manolos
CEO, CFO & Director
Dan Nguyen
Director

Names and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.

  • Form 1-A/AMar 13, 20230001079973-23-000312
    EDGAR
  • Form 1-A/ANov 30, 20220001079973-22-001474
    EDGAR
  • Form 1-A/ANov 16, 20220001079973-22-001455
    EDGAR
  • Form 1-AOct 7, 20220001079973-22-001304
    EDGAR
  • Form 10-QJul 20, 20220001079973-22-000868
    EDGAR
  • Form 10-QApr 19, 20220001079973-22-000453
    EDGAR
  • Form 10-QJan 18, 20220001079973-22-000076
    EDGAR
  • Form 10-KDec 14, 20210001079973-21-001237
    EDGAR
Source: SEC EDGARCIK 0001413488NVShare price $0.001Last synced Aug 16, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.